With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Preclinical Development of Atr Inhibitor VE-822, Delivered Systemically in Nanoparticles, for Medulloblastoma Therapy||University of North Carolina / Timothy Gershon, MD, PhD||Innovation Grants||2015||North Carolina|
|In Vivo Analysis of Early Neuroblastoma Development using Transgenic Quail||Stowers Institute for Medical Research / Paul Kulesa, PhD||Innovation Grants||2015||Missouri|
|Phase I and II Clinical Research Program Infrastructure Award||University of Minnesota / Brenda Weigel, MD & Emily Greengard MD||Phase I/II Infrastructure Grants||2015||Minnesota|
|Engager T Cells: A Novel Immunotherapeutic for AML||University of Michigan / Challice Bonifant, MD, PhD||Young Investigator Grants||2015||Michigan|
|Targeting the LIN28 Pathway in ATRT||The Johns Hopkins University School of Medicine / Eric Raabe, MD, PhD||'A' Award Grants||2015||Maryland|
|Circadian Rhythms, Fatigue and Bright Light Therapy in Adolescent Cancer Survivors||University of Maryland, College Park / Valerie E. Rogers, PhD||Nurse Researcher Grants||2015||Maryland|
|Developing a Novel Tumor Model to Screen for New Therapies for Spinal Ependymoma||The Johns Hopkins University School of Medicine / Linda Resar, MD & Richard Schlegel, MD, PhD||Innovation Grants||2015||Maryland|
|The Cebpa Downstream Enhancer as a Key Target of Transformation to Acute Myeloid Leukemia||The Johns Hopkins University School of Medicine / Stacy Cooper, MD||Young Investigator Grants||2015||Maryland|
|Elucidating Mechanisms Driving Renal Medullary Carcinomas to Deliver a Rational Approach to Cancer Directed Therapy||Dana-Farber Cancer Institute / Andrew Hong, MD||Young Investigator Grants||2015||Massachusetts|
|The Role of DEF and SSU Processome in Neuroblastoma Pathogenesis||Dana-Farber Cancer Institute / Ting Tao, PhD||Young Investigator Grants||2015||Massachusetts|